Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Agalsidase Beta | Fabrazyme | View | ||
| Daptomycin | DACI | View | ||
| Methotrexate | Methotrexate | View | ||
| Fingolimod | Olican | View | ||
| Vemurafenib | Vemurafenib | View | ||
| Cefoperazone | Cefoperazone | View | ||
| Alpelisib | Piqray | View | ||
| Luspatercept | Reblozyl | View | ||
| Rivaroxaban | Rivaroxaban SPC | View | ||
| Romosozumab | Evenity | View |